PRFX Stock Analysis: Buy, Sell, or Hold?
PRFX - PainReform Ltd. Ordinary Shares
$1.45
-0.15 (-9.38%)
▼
5d:
-41.77%
30d:
+0.0%
90d:
-36.4%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jun 25, 2026
1d
Get Alerted When PRFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PRFX is down 41.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PRFX is down 41.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRFX is currently trading at $1.45, which is considered fair relative to its 30-day fair value range of $1.32 to $2.05.
Technical Outlook: Technically, PRFX is showing sideways momentum. Immediate support is located at $1.30, while resistance sits at $5.39. Short-term momentum is weak, with the stock down 9.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+727.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRFX is showing sideways momentum. Immediate support is located at $1.30, while resistance sits at $5.39. Short-term momentum is weak, with the stock down 9.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+727.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.32 -
$2.05
Company Quality Score
51/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-9.4%)
- BULLISH: Trading 727.6% below Wall St target ($12.00)
- WARNING: Recommendation downgraded due to -41.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.32 -
$2.05
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.30
Resistance Level
$5.39
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$12.00
(+727.6%)
Share & Embed Analysis
Last updated: June 23, 2026 6:42 PM ET
Data refreshes hourly during market hours. Next update: 7:42 PM
Data refreshes hourly during market hours. Next update: 7:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
